To support better subcutaneous administration practices, rotate injection sites regularly between the abdomen, thighs, and upper arms
Very high baseline A1C and long-standing diabetes Pre-existing diabetic retinopathy or macular edema Concurrent insulin therapy Large and rapid A1C reductions over a short period Additional vascular risks such as high blood pressure, high cholesterol, kidney disease, or sleep apnea Improving glucose control remains important for long-term eye health
This innovative pharmacological strategy, along with the drug's ability to modulate synaptic plasticity, represents a crucial development in the efforts towards pharmacological interventions against obesity
IV hydration and the rapid repletion of a genuine deficiency are well established medicine
Metabolism The primary route of elimination for semaglutide is metabolism following proteolytic cleavage of the peptide backbone and sequential beta-oxidation of the fatty acid sidechain